-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2019 to Q2 2024.
- X4 Pharmaceuticals, Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $18K, a 20% increase year-over-year.
- X4 Pharmaceuticals, Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $96K, a 380% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Income Tax Expense (Benefit) for 2023 was $78K, a 179% increase from 2022.
- X4 Pharmaceuticals, Inc annual Income Tax Expense (Benefit) for 2022 was $28K, a 64.7% increase from 2021.
- X4 Pharmaceuticals, Inc annual Income Tax Expense (Benefit) for 2021 was $17K, a 88.5% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)